Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oxytocin
100%
Autism Spectrum Disorder
100%
Intranasal Oxytocin
100%
Oxytocin Administration
100%
Israel
57%
Adjusted Hazard Ratio
42%
Confidence Interval
28%
Sex Differences
28%
British Columbia
28%
Mental Health
14%
Sensitivity Analysis
14%
Social Behavior
14%
Adjusting for Covariates
14%
University Medical Centre
14%
Clinical Practice
14%
Study Support
14%
Cox Proportional Hazards Model
14%
Canada
14%
Induction of Labor
14%
International Comparison
14%
Population-based Retrospective Cohort Study
14%
Autism Spectrum Disorder Screening
14%
Adjusted Model
14%
Intrapartum
14%
Obstetric Practice
14%
Exposure Groups
14%
Stress Regulation
14%
Postdates
14%
Confounding by Indication
14%
Exposure Status
14%
Infant Sex
14%
Neuropeptide Hormone
14%
Oxytocin Induction
14%
Oxytocin Exposure
14%
Medicine and Dentistry
Pervasive Developmental Disorder
100%
Oxytocin
100%
Hazard Ratio
23%
Sex Differences
15%
Proportional Hazards Model
7%
Retrospective Cohort Study
7%
Mental Health
7%
Disease
7%
Intrapartum
7%
Neuropeptide
7%
Psychology
Pervasive Developmental Disorder
100%
Oxytocin
100%
Hazard Ratio
23%
Sex Differences
15%
Mental Health
7%
Proportional Hazards Regression Model
7%
Stress Regulation
7%
Neuroscience
Pervasive Developmental Disorder
100%
Oxytocin
100%
Social Behavior
7%
Neuropeptide
7%
Biochemistry, Genetics and Molecular Biology
Oxytocin
100%
Sex Differences
15%
Cohort Study
7%
Mental Health
7%
Neuropeptide
7%
Pharmacology, Toxicology and Pharmaceutical Science
Oxytocin
100%
Cohort Study
7%
Neuropeptide
7%